|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hammond SM: MicroRNAs as oncogenes. Curr
Opin Genet Dev. 16:4–9. 2006. View Article : Google Scholar
|
|
3
|
Croce CM and Calin GA: miRNAs, cancer and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
|
7
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Zhang B, Li W, Fu L, Fu L, Zhu Z
and Dong JT: Epigenetic silencing of miR-203 upregulates SNAI2 and
contributes to the invasiveness of malignant breast cancer cells.
Genes Cancer. 2:782–791. 2011. View Article : Google Scholar
|
|
10
|
Li Y, Yuan Y, Tao K, Wang X, Xiao Q, Huang
Z, Zhong L, Cao W, Wen J and Feng W: Inhibition of BCR/ABL protein
expression by miR-203 sensitizes for imatinib mesylate. PloS One.
8:e618582013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu X, Er K, Mao C, Yan Q, Xu H, Zhang Y,
Zhu J, Cui F, Zhao W and Shi H: miR-203 suppresses tumor growth and
angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol
Biochem. 2:64–73. 2013. View Article : Google Scholar
|
|
12
|
Zhang J, Zhou Y, Wu YJ, Li MJ, Wang RJ,
Huang SQ, Gao RR, Ma L, Shi HJ and Zhang J: Hyper-methylated
miR-203 dysregulates ABL1 and contributes to the nickel-induced
tumorigenesis. Toxicol Lett. 223:42–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen
X, Gao Z, Xin J, Zhou S, Zhou Z, et al: MiR-203 suppresses tumor
growth and invasion and down-regulates MiR-21 expression through
repressing Ran in esophageal cancer. Cancer Lett. 342:121–129.
2014. View Article : Google Scholar
|
|
14
|
van den Heuvel S and Dyson NJ: Conserved
functions of the pRB and E2F families. Nat Rev Mol Cell Biol.
9:713–724. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ziebold U, Lee EY, Bronson RT and Lees JA:
E2F3 loss has opposing effects on different pRB-deficient tumors,
resulting in suppression of pituitary tumors but metastasis of
medullary thyroid carcinomas. Mol Cell Biol. 23:6542–6552. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parisi T, Yuan TL, Faust AM, Caron AM,
Bronson R and Lees JA: Selective requirements for E2f3 in the
development and tumorigenicity of Rb-deficient chimeric tissues.
Mol Cell Biol. 27:2283–2293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chong JL, Wenzel PL, Sáenz-Robles MT, Nair
V, Ferrey A, Hagan JP, Gomez YM, Sharma N, Chen HZ, Ouseph M, et
al: E2f1–3 switch from activators in progenitor cells to repressors
in differentiating cells. Nature. 462:930–934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Veltman JA, Fridlyand J, Pejavar S, Olshen
AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson
D, et al: Array-based comparative genomic hybridization for
genome-wide screening of DNA copy number in bladder tumors. Cancer
Res. 63:2872–2880. 2003.PubMed/NCBI
|
|
19
|
Orlic M, Spencer CE, Wang L and Gallie BL:
Expression analysis of 6p22 genomic gain in retinoblastoma. Genes
Chromosomes Cancer. 45:72–82. 2006. View Article : Google Scholar
|
|
20
|
Oeggerli M, Tomovska S, Schraml P,
Calvano-Forte D, Schafroth S, Simon R, Gasser T, Mihatsch MJ and
Sauter G: E2F3 amplification and overexpression is associated with
invasive tumor growth and rapid tumor cell proliferation in urinary
bladder cancer. Oncogene. 23:5616–5623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Feber A, Clark J, Goodwin G, Dodson AR,
Smith PH, Fletcher A, Edwards S, Flohr P, Falconer A, Roe T, et al:
Amplification and overexpression of E2F3 in human bladder cancer.
Oncogene. 23:1627–1630. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grasemann C, Gratias S, Stephan H, Schüler
A, Schramm A, Klein-Hitpass L, Rieder H, Schneider S, Kappes F,
Eggert A and Lohmann DR: Gains and overexpression identify DEK and
E2F3 as targets of chromosome 6p gains in retinoblastoma. Oncogene.
24:6441–6449. 2005.PubMed/NCBI
|
|
23
|
Andre F, Job B, Dessen P, Tordai A,
Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, et al:
Molecular characterization of breast cancer with high-resolution
oligonucleotide comparative genomic hybridization array. Clin
Cancer Res. 15:441–451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foster CS, Falconer A, Dodson AR, Norman
AR, Dennis N, Fletcher A, Southgate C, Dowe A, Dearnaley D, Jhavar
S, et al: Transcription factor E2F3 overexpressed in prostate
cancer independently predicts clinical outcome. Oncogene.
23:5871–5879. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Borczuk A, Gorenstein L, Walter KL, Assaad
AA, Wang L and Powell CA: Non-small-cell lung cancer molecular
signatures recapitulate lung developmental pathways. Am J Pathol.
163:1949–1960. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu KH, Patterson AP, Wang L, Marquez RT,
Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I,
et al: Selection of potential markers for epithelial ovarian cancer
with gene expression arrays and recursive descent partition
analysis. Clin Cancer Res. 10:3291–3300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng B, Wang R, Song HZ and Chen LB:
MicroRNA-200b reverses chemoresistance of docetaxel-resistant human
lung adenocarcinoma cells by targeting E2F3. Cancer. 118:3365–3376.
2012. View Article : Google Scholar
|
